Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
Sliwa
Karen
K
Hatter Cardiovascular Research Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Rd, Observatory, Cape Town 7925, South Africa. sliwa-hahnlek@mdh-africa.org
Blauwet
Lori
L
Tibazarwa
Kemi
K
Libhaber
Elena
E
Smedema
Jan-Peter
JP
Becker
Anthony
A
McMurray
John
J
Yamac
Hatice
H
Labidi
Saida
S
Struman
Ingrid
I
Struhman
Ingrid
I
Hilfiker-Kleiner
Denise
D
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001971:Bromocriptine / Q000008:administration & dosage*; D009202:Cardiomyopathies / Q000000981:diagnostic imaging / Q000188:drug therapy*; D002402:Cathepsin D / Q000097:blood; D005260:Female; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000188:drug therapy; D006727:Hormone Antagonists / Q000008:administration & dosage*; D006801:Humans; D007231:Infant, Newborn; D008875:Middle Aged; D036801:Parturition; D010865:Pilot Projects; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011388:Prolactin / Q000097:blood; D013923:Thromboembolism / Q000175:diagnosis; D016896:Treatment Outcome; D014463:Ultrasonography; D016277:Ventricular Function, Left / Q000187:drug effects; D055815:Young Adult
D006727:Hormone Antagonists; D001971:Bromocriptine; D011388:Prolactin; C533922:CTSD protein, human; D002402:Cathepsin D